We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$1.95B
AUM Growth
-$288M
Cap. Flow
-$416M
Cap. Flow %
-21.35%
Top 10 Hldgs %
27.08%
Holding
2,541
New
186
Increased
41
Reduced
1,895
Closed
234

Sector Composition

Rank Sector Weight
1 Technology 22.13%
2 Healthcare 11.84%
3 Financials 10.45%
4 Consumer Discretionary 8.73%
5 Industrials 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALCO icon
2026
Alico
ALCO
$303M
$9.61K ﹤0.01%
397
ARIS
2027
DELISTED
Aris Water Solutions
ARIS
$9.57K ﹤0.01%
1,228
-428
-26% -$5.52K
WEYS icon
2028
Weyco Group
WEYS
$437M
$9.54K ﹤0.01%
377
BBCP icon
2029
Concrete Pumping Holdings
BBCP
$477M
$9.53K ﹤0.01%
1,402
-245
-15% -$1.78K
AKYA
2030
DELISTED
Akoya BioSciences
AKYA
$9.53K ﹤0.01%
1,165
DNMR
2031
DELISTED
Danimer Scientific, Inc.
DNMR
$9.42K ﹤0.01%
68
-94
-58% -$8.6K
SLQT icon
2032
SelectQuote
SLQT
$129M
$9.38K ﹤0.01%
+4,322
New +$6.97K
LAW icon
2033
CS Disco
LAW
$297M
$9.38K ﹤0.01%
1,412
-156
-10% -$1.11K
ORRF icon
2034
Orrstown Financial Services
ORRF
$850M
$9.37K ﹤0.01%
472
-271
-36% -$6.15K
OTLK icon
2035
Outlook Therapeutics
OTLK
$163M
$9.36K ﹤0.01%
+429
New +$9.6K
CBNK icon
2036
Capital Bancorp
CBNK
$613M
$9.34K ﹤0.01%
561
ZIMV
2037
DELISTED
ZimVie
ZIMV
$9.3K ﹤0.01%
1,286
-136
-10% -$1.16K
PRPL icon
2038
Purple Innovation
PRPL
$28.8M
$9.25K ﹤0.01%
140
-1
-0.7% -$112
OPRX icon
2039
OptimizeRx
OPRX
$165M
$9.17K ﹤0.01%
627
-479
-43% -$8.02K
NGM
2040
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$9.16K ﹤0.01%
2,246
-146
-6% -$675
KZR
2041
DELISTED
Kezar Life Sciences
KZR
$9.09K ﹤0.01%
290
-29
-9% -$1.68K
NC icon
2042
NACCO Industries
NC
$313M
$9.05K ﹤0.01%
251
AXTI icon
2043
AXT Inc
AXTI
$5.06B
$8.99K ﹤0.01%
2,258
+264
+13% +$1.28K
CLAR icon
2044
Clarus
CLAR
$144M
$8.96K ﹤0.01%
948
-723
-43% -$6.79K
CRGE
2045
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$8.95K ﹤0.01%
8,134
-656
-7% -$826
DHX icon
2046
DHI Group
DHX
$172M
$8.9K ﹤0.01%
2,295
-399
-15% -$1.89K
CANO
2047
DELISTED
Cano Health, Inc.
CANO
$8.84K ﹤0.01%
97
-5
-5% -$679
PRME icon
2048
Prime Medicine
PRME
$571M
$8.83K ﹤0.01%
718
BWFG icon
2049
Bankwell Financial Group
BWFG
$542M
$8.8K ﹤0.01%
354
HLLY icon
2050
Holley
HLLY
$364M
$8.79K ﹤0.01%
3,207
-531
-14% -$1.36K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q1 2023 Portfolio in Review

As of Q1 2023, Metropolitan Life Insurance Company (MetLife) held 2,541 positions worth $1.95B, down 13% from $2.24B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $416M in Q1 2023, closing 234 positions and reducing 1,895 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $26.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Insulet worth $991K.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q1 2023 buy was Insulet: 3,107 shares worth $991K.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q1 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q1 2023 reduction was Apple, cutting an estimated $24.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q1 2023, selling an estimated $26.1M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 27% of its $1.95B portfolio in Q1 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 186 new positions and closed 234 in Q1 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 13% quarter-over-quarter to $1.95B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.